Halozyme Therapeutics HALO
NASDAQ HALO
$109.86 +2.92 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Other Operating Expenses (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) reported Other Operating Expenses of $108.68 million for Q2 2026, up 69.5% from $64.12 million a year earlier but down 0.1% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Other Operating Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' Other Operating Expenses came in at $726.17 million, up 182.2% year-over-year; for FY2025, it was $639.02 million, up 177.3% from FY2024.

  • Other Operating Expenses has a five-year compound annual growth rate of 71.3% (FY2020 to FY2025).
  • By year, Other Operating Expenses came in at $230.47 million in FY2024 (-13.4%), $266.13 million in FY2023 (+45.9%), $182.45 million in FY2022 (+124.1%) and $81.41 million in FY2021 (+87.7%).
  • Five-year quarterly Other Operating Expenses spans a low of $15.92 million in Q1 2022 and a high of $435.73 million in Q4 2025.
  • Year over year, Other Operating Expenses has now increased in each of the last six quarters, with growth averaging 100.1% over the last eight quarters.
  • The high point for year-over-year Other Operating Expenses in five years was Q4 2025 (growth of 628.4%); the low point was Q4 2021 (a decline of 17.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $108.75 million (Q1 2026), $435.73 million (Q4 2025) and $73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Halozyme Therapeutics 12.20 Bn 10.80 Bn 401.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.68 Mn
Mar 31, 2026 108.75 Mn
Dec 31, 2025 435.73 Mn
Sep 30, 2025 73.00 Mn
Jun 30, 2025 64.12 Mn
Mar 31, 2025 66.17 Mn
Dec 31, 2024 59.82 Mn
Sep 30, 2024 67.19 Mn
Jun 30, 2024 57.37 Mn
Mar 31, 2024 46.09 Mn
Dec 31, 2023 70.06 Mn
Sep 30, 2023 75.16 Mn
Jun 30, 2023 67.91 Mn
Mar 31, 2023 53.01 Mn
Dec 31, 2022 46.67 Mn
Sep 30, 2022 74.51 Mn
Jun 30, 2022 45.35 Mn
Mar 31, 2022 15.92 Mn
Dec 31, 2021 21.59 Mn
Sep 30, 2021 18.59 Mn
API Access

Halozyme Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=HALO&period=max&api_key=YOUR_API_KEY